[Minor liver resection for hilar cholangiocarcinoma of Bismuth-Corlette type III]
Xiao-ping Chen1, Zhi-yong Huang, Zhi-wei Zhang
1Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. chenxp@medmail.com.cn
Insights
Minor liver resection offers better long-term outcomes for selected hilar cholangiocarcinoma (HC) patients. A novel hepaticojejunostomy technique is safe and effective for these procedures.
Area of Science:
- Hepatobiliary surgery
- Surgical oncology
- Gastroenterology
Context:
- Hilar cholangiocarcinoma (HC), specifically Bismuth-Corlette type III, presents surgical challenges.
- Traditional major hepatectomy may not always be optimal for all HC cases.
- Evaluating minimally invasive approaches is crucial for improving patient outcomes.
Purpose:
- To assess the long-term efficacy of minor liver resection for Bismuth-Corlette type III hilar cholangiocarcinoma.
- To introduce and evaluate a novel hepaticojejunostomy technique in conjunction with minor hepatectomy.
- To compare outcomes between minor and major hepatectomy for this specific HC subtype.
Summary:
- A retrospective analysis of 91 patients with Bismuth-Corlette type III HC undergoing hepatectomy was conducted.
- 60 patients underwent minor hepatectomy with a new hepaticojejunostomy technique, while 31 had major hepatectomy.
- The novel hepaticojejunostomy involved suturing the jejunum loop to the remnant liver, omitting anterior bile duct stump suturing.
Impact:
- Minor liver resection, coupled with the innovative hepaticojejunostomy, demonstrated favorable long-term survival rates without increasing mortality or bile leakage.
- The study suggests that minor hepatectomy can be a safe and effective option for carefully selected HC patients.
- This approach may offer an alternative to more extensive resections, potentially improving quality of life and recovery for HC patients.
Objective:
To evaluate long-term outcomes of minor liver resection for hilar cholangiocarcinoma (HC) of Bismuth-Corlette type III.
Methods:
From January 1997 to December 2007, the clinical data of 91 patients with Bismuth-Corlette type III HC underwent hepatectomy were collected and analyzed retrospectively.
Results:
There were 60 patients underwent minor hepatectomy, and 31 undergoing major hepatectomy. Hepaticojejunostomy was made conventionally in an end-to-side fashion in the patients undergoing major liver resection, and a new technique of hepaticojejunostomy used in the patients undergoing minor liver resection. That was the anterior edges of bile duct stumps which were not sutured after suturing of posterior edges. Instead of, the anterior edge of jejunum loop to the remnant liver on the top of the bile duct stumps were sutured with intermittent "U" sutures. In all patients, in-hospital mortality rate was 0 and rate of bile leakage was only 2.1%. The actual 1-, 3- and 5-year survival rates were 91.6% and 87.0%, 61.6% and 62.0%, 31.6% and 33.0%, respectively (P > 0.05).
Conclusions:
Minor liver resection for the selected patients with HC of Bismuth-Corlette type III according to our criteria achieved better long-term outcomes. A new hepaticojejunostomy used in the patients undergoing minor liver resection is a safe and effective method.
